In a regulatory filing, Moleculin Biotech disclosed that its CEO Walter Klemp bought 188K shares of common stock on December 26th in a total transaction size of $130K.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MBRX:
- Moleculin Biotech sells 7.044M shares at 64c in registered direct offering
- Moleculin Biotech initiated with bullish view at H.C. Wainwright, here’s why
- Moleculin Biotech presents interim data from Phase 1B/2 trial in AML
- Biotech Alert: Searches spiking for these stocks today
- Moleculin Biotech announces interim data in annamycin trials
